A new preclinical study demonstrates that CBD glioblastoma prevention may be possible through extended pretreatment in mice. While promising, this early research requires extensive human studies before any clinical applications. Dr. Caplan explains what patients should understand about this brain cancer prevention research.
Cannabidiol: Attenuation of behavioral and cognitive schizophrenia symptoms leads to potential clinical applications
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors In Summary Although cannabidiol (CBD), a major constituent of the plant cannabis, is known...